Guidelines for immunization of children following multisystem inflammatory syndrome in children
Pediatria Polska
; 97(2):81-88, 2022.
Article
in English
| EMBASE | ID: covidwho-1969656
ABSTRACT
Multisystem inflammatory syndrome in children (MIS-C) is a late complication of SARS-CoV-2 infection, either symptomatic or asymptomatic. The underlying cause is immunological dysregulation, leading to severe inflammatory processes. Children with MIS-C require hospital treatment, the use of immunomodulating drugs, and often intensive care. COVID-19 vaccination is safe and highly effective in preventing not only severe COVID-19, but also MIS-C in adolescents. However, there are no explicit vaccination recommendations for children who underwent MIS-C. We present a summary of current knowledge on vaccinations against COVID-19 in the context of MIS-C. Moreover, we propose guidance concerning vaccinations for children following MIS-C.
adolescent; article; child; complication; coronavirus disease 2019; human; immunization; inflammation; intensive care; nonhuman; pediatric multisystem inflammatory syndrome; practice guideline; prevention; Severe acute respiratory syndrome coronavirus 2; vaccination; immunomodulating agent; tozinameran
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
Pediatria Polska
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS